United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.
Quick Stats
Apr 01, 202666.6
AI Score
BUY1.2
Volume Ratio
Apr 29, 2026
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
UTHR Stock Summary
Last updated Apr 01, 2026
UTHR is currently trading at $570.27, positioned above its 200-day moving average of $425.7, indicating a long-term uptrend. The stock has a 52-week range of $266.98 to $607.89.
Technical Analysis: The 50-day moving average stands at $502.85, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 61.693, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.004, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates UTHR at 66.6/100 with a BUY recommendation.
UTHR (United Therapeutics Corp) Indicators
Last updated Apr 01, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 61.693 |
| CMF (20) | -0.004 |
| ROC (10) | 7.527 |
| ADX (14) | 36.953 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 17.978 |
| AROONOSC (14) | 28.571 |
| WILLAMS %R (14) | -41.659 |
| MFI (14) | 48.567 |
UTHR Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
UTHR Price vs Max Options Open Interest
UTHR Max Change In Options Open Interest
UTHR Options - Sort by Max open Interest (near term)
2nd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
UTHR Daily Out of Money Options - Sort by Max open Interest (near term)
2nd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
UTHR Daily In the Money Options - Sort by Max open Interest (near term)
2nd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
UTHR Most Active Options by Volume(near term)
2nd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
United Therapeutics Corp is above both 50 Day and 200 Day SMA which is considered Bullish.
UTHR Moving Averages Analysis
United Therapeutics Corp has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Apr 01, 2026
United Therapeutics Corp has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Apr 01, 2026
UTHR (United Therapeutics Corp) Simple Moving Averages
Moving Averages are last updated Apr 01, 2026
| Days | MA |
|---|---|
| 10 | 545.29 |
| 20 | 534.97 |
| 30 | 521.55 |
| 50 | 502.85 |
| 100 | 493.54 |
| 200 | 425.7 |
UTHR Fundamental Analysis
| P/E (Forward) | 15.2905 |
| P/E (Trailing) | 21.2843 |
| Market Cap ($) | 26.0 billion |
| Earnings/Share ($) | 27.86 |
| Net Proft Margin (%) | 0.4194 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 28.0053 |
| EPS Estimate Next Year ($) | 32.246 |
| WallStreet Target Price ($) | 605.75 |
| Most Recent Quarter |